Ironwood Pharmaceuticals, Inc.

IRWD · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income$40$24-$37$3
Dep. & Amort.$0$0$0$0
Deferred Tax$28$14$1$41
Stock-Based Comp.$4$5$5$0
Change in WC-$25-$59$50-$34
Other Non-Cash$1$1$1$4
Operating Cash Flow$48-$15$20$15
Investing Activities
PP&E Inv.-$0-$0-$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$0-$0-$0$0
Financing Activities
Debt Repay.$0$0$0-$13
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0-$2
Financing Cash Flow$0$0$0-$15
Forex Effect-$0-$1-$0$0
Net Chg. in Cash$48-$16$20$0
Supplemental Information
Beg. Cash$93$108$89$88
End Cash$140$93$108$89
Free Cash Flow$48-$15$20$15
Ironwood Pharmaceuticals, Inc. (IRWD) Financial Statements & Key Stats | AlphaPilot